The gain-of-function of HOXA5 in CC cell lines confirmed that HOXA5 could act as a tumor suppressor by inducing the expression of cell cycle inhibitor p27 and suppressing the phosphorylation of AKT (Wang et al. 2019c). The gene discussed is HOXA5; the disease is cholangiocarcinoma.